UL Solutions director gets 19 dividend stock units

Director Elisabeth Torstad received additional deferred restricted stock units linked to dividend equivalents on prior UL Solutions Inc. awards.

Rhea-AI Filing Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. Torstad Elisabeth reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that director Elisabeth Torstad received grants of deferred restricted stock units (DRSUs) on September 10, 2026. These awards reflect 19 DRSUs in total, representing dividend equivalent rights tied to previously granted DRSUs, each convertible into one share of Class A Common Stock at no cash cost.

Insider Trade Summary

Grant/Award: 19 shares

Grant/Award 3 txns

Insider Torstad Elisabeth

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Restricted Stock Units F1, F2, F3, F4	10	$0.00	$0.00
Grant/Award	Deferred Restricted Stock Units F1, F2, F5, F4	5	$0.00	$0.00
Grant/Award	Deferred Restricted Stock Units F1, F2, F6, F4	4	$0.00	$0.00

Holdings After Transaction: Deferred Restricted Stock Units — 10,006 contracts (Direct)

Footnotes (6)

1. F1. Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2. F2. Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.
3. F3. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.
4. F4. Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.
5. F5. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.
6. F6. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

Key Figures

DRSUs granted (first tranche): 10 units DRSUs granted (second tranche): 5 units DRSUs granted (third tranche): 4 units +3 more

6 metrics

DRSUs granted (first tranche) 10 units Deferred restricted stock units granted September 10, 2026, tied to dividend equivalents

DRSUs granted (second tranche) 5 units Additional dividend-equivalent DRSUs granted September 10, 2026

DRSUs granted (third tranche) 4 units Additional dividend-equivalent DRSUs granted September 10, 2026

Total DRSUs reported 19 units Sum of the three dividend-equivalent DRSU grants reported for September 10, 2026

Underlying Class A Common Stock per DRSU 1 share Each DRSU represents a contingent right to receive one share of Class A Common Stock

Grant price per DRSU $0.00 Reported transaction price per deferred restricted stock unit

Key Terms

Deferred Restricted Stock Units, dividend equivalent rights, Non-Employee Director Deferred Compensation Plan

3 terms

Deferred Restricted Stock Units financial

"Each deferred restricted stock unit ("DRSU") represents a contingent right"

Deferred restricted stock units are promises by a company to give employees or executives company shares at a future date, subject to conditions like continued employment or performance targets; the delivery and tax event are intentionally delayed. They matter to investors because they affect when new shares may be issued and how executives are motivated—like a paycheck held in escrow that vests over time, influencing potential share dilution and management behavior.

dividend equivalent rights financial

"Represents accrual of dividend equivalent rights on DRSUs held"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

Non-Employee Director Deferred Compensation Plan financial

"pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did UL Solutions Inc. (ULS) disclose for Elisabeth Torstad?

The filing reports that director Elisabeth Torstad received additional deferred restricted stock units on September 10, 2026, representing dividend equivalent rights on existing DRSUs, each convertible into one share of Class A Common Stock.

How many deferred restricted stock units were granted to the UL Solutions (ULS) director?

Elisabeth Torstad was granted DRSUs covering 10 shares, 5 shares, and 4 shares of Class A Common Stock, for a total of 19 DRSUs representing dividend equivalent rights on previously held awards.

Were cash payments involved in the UL Solutions (ULS) DRSU grants to the director?

No. The reported DRSU grants show a per-unit price of $0.00. Each DRSU represents a contingent right to receive one share of Class A Common Stock, reflecting accrued dividend equivalent rights rather than a cash transaction.

When do the underlying DRSUs for the UL Solutions (ULS) dividend equivalents vest and settle?

Related DRSUs vested on May 1, 2025 and May 20, 2026, and another tranche vests on the earlier of May 20, 2027 or the next annual meeting. Settlement occurs in Class A Common Stock under the company’s Non-Employee Director Deferred Compensation Plan.

Was a Rule 10b5-1 trading plan involved in the UL Solutions (ULS) Form 4?

No. The Form 4 indicates that no Rule 10b5-1 plan is reported in connection with these DRSU acquisitions; they arise from the company’s compensation and dividend equivalent arrangements for a non-employee director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 05:42 PM Accepted by SEC EDGAR 09/14/2026 - 05:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Torstad Elisabeth

(Last) (First) (Middle)

C/O UL SOLUTIONS INC.

333 PFINGSTEN ROAD

(Street)

NORTHBROOK ILLINOIS 60062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UL Solutions Inc. [ ULS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Restricted Stock Units	(1)	09/10/2026		A		10(2)		(3)	(3)	Class A Common Stock	10	$0	4,979(4)	D
Deferred Restricted Stock Units	(1)	09/10/2026		A		5(2)		(5)	(5)	Class A Common Stock	5	$0	2,814(4)	D
Deferred Restricted Stock Units	(1)	09/10/2026		A		4(2)		(6)	(6)	Class A Common Stock	4	$0	2,213(4)	D

Explanation of Responses:

1. Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

2. Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.

3. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

4. Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.

5. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

6. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

	/s/ Ryan Robinson, Attorney-in-Fact	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)